Cremophor EL
Top Cited Papers
- 1 September 2001
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (13) , 1590-1598
- https://doi.org/10.1016/s0959-8049(01)00171-x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patientsAnti-Cancer Drugs, 2000
- Titrimetric determination of Cremophor® EL in aqueous solutions and biofluidsJournal of Pharmaceutical and Biomedical Analysis, 1999
- Effects of Taxol on blood cellsThe Lancet, 1998
- Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine: Case Report and ReviewAnnals of Allergy, Asthma & Immunology, 1998
- Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse modelsAnti-Cancer Drugs, 1996
- Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant PhenotypeJNCI Journal of the National Cancer Institute, 1993
- Is Cremophor EL, solvent for paclitaxel, cytotoxic?The Lancet, 1993
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Unusual Serum Lipoprotein Abnormality Induced by the Vehicle of MiconazoleNew England Journal of Medicine, 1977
- Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituentInflammation Research, 1977